Nipro Overview
Update this profile
Share Price
$8.01
(As of Tuesday Closing)
Nipro General Information
Description
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
Contact Information
Want to dig into this profile?
We’ll help you find what you need
Learn more
Nipro Stock Performance
(As of Tuesday Closing)
Stock Price
Previous Close
52 wk Range
Market Cap
Shares
Average Volume
EPS
$8.01
$8.03
$7.43 - $12.78
$1.31B
163M
393K
$0.73
Nipro Financials Summary
In Thousands, USD
TTM
31-Mar-2022
FY 2022
31-Mar-2022
FY 2021
31-Mar-2021
FY 2020
31-Mar-2020
EV
5,658,229
5,658,229
6,772,230
6,174,147
Revenue
4,404,261
4,404,261
4,296,125
4,069,768
EBITDA
648,664
648,664
598,598
315,214
Net Income
119,767
119,767
133,997
(112,947)
Total Assets
7,622,585
7,622,585
7,745,014
7,697,247
Total Debt
4,628,115
4,628,115
4,942,936
5,008,834
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Nipro Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore Nipro‘s full profile, request access.
Request a free trial
Nipro Comparisons
Description
Primary Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in f
Medical Supplies
Osaka, Japan
37,235
As of 2022
00000000
dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000 00000000
Tokyo, Japan
00000
As of 0000
00000000
ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000 00000000
Exton, PA
00000
As of 0000
00000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trial
Nipro Competitors (13)
Company Name
Financing Status
Location
Employees
Total Raised
Last Financing Date/Type
Last Financing Amount
Terumo
Corporation
Tokyo, Japan
00000
00000000
0000 0000000000000
Corporation
Exton, PA
00000
00000000
000000000000000 00
Corporation
Lagos, Nigeria
00
00000000 000000 00
Corporation
Weihai, China
00000
00000
000000 - 000
00000
000000 0000000
Corporation
Kobe, Japan
0000
00000000
You’re viewing 5 of 13 competitors. Get the full list »
Nipro Patents
1,851
Total Documents
Applications and Grants
000
Total Patents
Families
131
Granted
25
Pending
000
Expiring
in next 12 mo
Nipro Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
US-20210383531-A1
Foreign matter inspection system and foreign matter inspection method
Pending
31-Oct-2018
0000000000
DE-102018006961-A1
Hollow glass body and use of a hollow glass body
Pending
03-Sep-2018
000000000
DE-102018006968-A1
Method for separating a hollow glass body from a glass tube and method and system for producing a container
Pending
03-Sep-2018
000000000
EP-3847137-A1
Hollow glass body and use of a hollow glass body
Pending
03-Sep-2018
000000000
EP-3847138-A1
Method for separating a hollow glass body from a glass tube as well as method and system for manufacturing a receptacle
Pending
03-Sep-2018
A61J1/065
To view Nipro’s complete patent history, request access »
Nipro Executive Team (5)
Update this profile
Name
Title
Board Seat
Contact Info
Yoshihiko Sano
Board Member & President
Kiyotaka Yoshioka
Board Member & General Manager
Kyoetsu Kobayashi
Board Member & General Manager
Toshiaki Masuda
Board Member & General Manager
You’re viewing 4 of 5 executive team members. Get the full list »
Nipro Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Nipro
Investments & Acquisitions (24)
Company Name
Deal Date
Deal Type
Deal Size
Industry
Lead Partner
00000000 (000
03-Apr-2021
0000000000
Other Containers and Packaging
000000000
000000 000000
28-Oct-2020
0000 00000
00.00
Therapeutic Devices
00000000
0000000 000
03-Mar-2020
0000000000
Specialty Chemicals
000000 00
000000000 000
01-Jan-2018
0000000000
Surgical Devices
TC Biopharm
18-Jan-2017
Early Stage VC
00.000
Drug Discovery
You’re viewing 5 of 24 investments and acquisitions. Get the full list »
Nipro Subsidiaries (8)
Company Name
Industry
Location
Founded
Dimesol USA
Specialty Chemicals
Lewisberry, PA
2016
0000 0000000 & 000
Biotechnology
Aoba-ku, Japan
0000
000000000
Diagnostic Equipment
Burlington, MA
0000
00000 000000
Mechelen, Belgium
0000
00000000 (0000000)
Other Containers and Packaging
Sesvete, Croatia
0000
You’re viewing 5 of 8 subsidiaries. Get the full list »
Nipro Exits (3)
Company Name
Exit Date
Exit Type
Exit Size
Status
Buyers
0000000 000000
15-Mar-2010
000000000000000000
00000
Completed
000000000
07-Oct-2008
00000 00000 00
00.000
Completed
Bipha
01-Feb-2001
Secondary Transaction - Private
Completed
To view Nipro’s complete exits history, request access »